Conditions: Severe Persistent Asthma; Eosinophilic Bronchitis
Interventions: Biological: Reslizumab; Drug: Placebo
Sponsors: McMaster University; Teva Pharmaceuticals USA; St. Joseph’s Healthcare Hamilton
Not yet recruiting – verified September 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days